Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,713.74 +375.20 (+0.56%) CMC Crypto 200
1,424.08 -4.49 (-0.31%)
CRL Nov 2024 240.000 call
| Previous close | 15.75 |
| Open | 10.40 |
| Bid | 7.20 |
| Ask | 11.30 |
| Strike | 240.00 |
| Expiry date | 2024-11-15 |
| Day's range | 10.40 - 10.40 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
ZacksCharles River (CRL) Launches Viral Vector Tech Transfer Program
Charles River's (CRL) new Fast Track and Modular frameworks facilitate product development continuity via accelerated process transfer to its viral vector Center of Excellence.
Business WireCharles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
WILMINGTON, Mass., May 30, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks. Based on decades of viral vector contract development and manufacturing organization (CDMO) experience, the Company has designed a methodical program to drive successful, accelerated process transfer to its Maryland-based viral vector center of excellence (CoE) in as little as nine months.
ZacksReasons to Hold Charles River (CRL) in Your Portfolio Now
Investors remain optimistic about Charles River (CRL), owing to its acquisitions, thriving DSA segment and financial stability.
